Literature DB >> 19122635

Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells.

Andrea Viale1, Francesca De Franco, Annette Orleth, Valeria Cambiaghi, Virginia Giuliani, Daniela Bossi, Chiara Ronchini, Simona Ronzoni, Ivan Muradore, Silvia Monestiroli, Alberto Gobbi, Myriam Alcalay, Saverio Minucci, Pier Giuseppe Pelicci.   

Abstract

Rare cells with the properties of stem cells are integral to the development and perpetuation of leukaemias. A defining characteristic of stem cells is their capacity to self-renew, which is markedly extended in leukaemia stem cells. The underlying molecular mechanisms, however, are largely unknown. Here we demonstrate that expression of the cell-cycle inhibitor p21 is indispensable for maintaining self-renewal of leukaemia stem cells. Expression of leukaemia-associated oncogenes in mouse haematopoietic stem cells (HSCs) induces DNA damage and activates a p21-dependent cellular response, which leads to reversible cell-cycle arrest and DNA repair. Activated p21 is critical in preventing excess DNA-damage accumulation and functional exhaustion of leukaemic stem cells. These data unravel the oncogenic potential of p21 and suggest that inhibition of DNA repair mechanisms might function as potent strategy for the eradication of the slowly proliferating leukaemia stem cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19122635     DOI: 10.1038/nature07618

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  46 in total

1.  Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation.

Authors:  S Minucci; M Maccarana; M Cioce; P De Luca; V Gelmetti; S Segalla; L Di Croce; S Giavara; C Matteucci; A Gobbi; A Bianchini; E Colombo; I Schiavoni; G Badaracco; X Hu; M A Lazar; N Landsberger; C Nervi; P G Pelicci
Journal:  Mol Cell       Date:  2000-05       Impact factor: 17.970

Review 2.  Core-binding factors in haematopoiesis and leukaemia.

Authors:  Nancy A Speck; D Gary Gilliland
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

Review 3.  Concepts of human leukemic development.

Authors:  Jennifer K Warner; Jean C Y Wang; Kristin J Hope; Liqing Jin; John E Dick
Journal:  Oncogene       Date:  2004-09-20       Impact factor: 9.867

Review 4.  The DNA damage response during DNA replication.

Authors:  Dana Branzei; Marco Foiani
Journal:  Curr Opin Cell Biol       Date:  2005-10-13       Impact factor: 8.382

5.  A Limited role for p21Cip1/Waf1 in maintaining normal hematopoietic stem cell functioning.

Authors:  Ronald van Os; Leonie M Kamminga; Albertina Ausema; Leonid V Bystrykh; Deanna P Draijer; Kyrjon van Pelt; Bert Dontje; Gerald de Haan
Journal:  Stem Cells       Date:  2006-12-14       Impact factor: 6.277

6.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

7.  Isolation in a single step of a highly enriched murine hematopoietic stem cell population with competitive long-term repopulating ability.

Authors:  S J Szilvassy; P M Lansdorp; R K Humphries; A C Eaves; C J Eaves
Journal:  Blood       Date:  1989-08-15       Impact factor: 22.113

8.  Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

Authors:  Fumihiko Ishikawa; Shuro Yoshida; Yoriko Saito; Atsushi Hijikata; Hiroshi Kitamura; Satoshi Tanaka; Ryu Nakamura; Toru Tanaka; Hiroko Tomiyama; Noriyuki Saito; Mitsuhiro Fukata; Toshihiro Miyamoto; Bonnie Lyons; Koichi Ohshima; Naoyuki Uchida; Shuichi Taniguchi; Osamu Ohara; Koichi Akashi; Mine Harada; Leonard D Shultz
Journal:  Nat Biotechnol       Date:  2007-10-21       Impact factor: 54.908

9.  Transgenic expression of E2F3a causes DNA damage leading to ATM-dependent apoptosis.

Authors:  Q X Paulson; R V Pusapati; S Hong; R L Weaks; C J Conti; D G Johnson
Journal:  Oncogene       Date:  2008-05-12       Impact factor: 9.867

10.  Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure.

Authors:  D E Harrison; C M Astle
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more
  132 in total

1.  Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.

Authors:  Raphael Ceccaldi; Kalindi Parmar; Enguerran Mouly; Marc Delord; Jung Min Kim; Marie Regairaz; Marika Pla; Nadia Vasquez; Qing-Shuo Zhang; Corinne Pondarre; Régis Peffault de Latour; Eliane Gluckman; Marina Cavazzana-Calvo; Thierry Leblanc; Jérôme Larghero; Markus Grompe; Gérard Socié; Alan D D'Andrea; Jean Soulier
Journal:  Cell Stem Cell       Date:  2012-06-07       Impact factor: 24.633

2.  Clinically relevant doses of chemotherapy agents reversibly block formation of glioblastoma neurospheres.

Authors:  Alicia M Mihaliak; Candace A Gilbert; Li Li; Marie-Claire Daou; Richard P Moser; Andrew Reeves; Brent H Cochran; Alonzo H Ross
Journal:  Cancer Lett       Date:  2010-10-28       Impact factor: 8.679

3.  A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors.

Authors:  Elisabeth Simboeck; Anna Sawicka; Gordin Zupkovitz; Silvia Senese; Stefan Winter; Franck Dequiedt; Egon Ogris; Luciano Di Croce; Susanna Chiocca; Christian Seiser
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

Review 4.  [Tumor stem cell research - basis and challenge for diagnosis and therapy].

Authors:  Heidrun Karlic; Harald Herrmann; Axel Schulenburg; Thomas W Grunt; Sylvia Laffer; Irina Mirkina; Rainer Hubmann; Medhat Shehata; Brigitte Marian; Edgar Selzer; Michael Pfeilstöcker; Elisabeth Pittermann; Ulrich Jäger; Hubert Pehamberger; Christoph Zielinski; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2010-07-22       Impact factor: 1.704

Review 5.  Nanoparticles: a promising modality in the treatment of sarcomas.

Authors:  Michiro Susa; Lara Milane; Mansoor M Amiji; Francis J Hornicek; Zhenfeng Duan
Journal:  Pharm Res       Date:  2010-05-27       Impact factor: 4.200

6.  p21 shapes cancer evolution.

Authors:  Vasily S Romanov; K Lenhard Rudolph
Journal:  Nat Cell Biol       Date:  2016-06-28       Impact factor: 28.824

7.  Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential.

Authors:  Ines Martin-Padura; Paola Marighetti; Giuliana Gregato; Alice Agliano; Omar Malazzi; Patrizia Mancuso; Giancarlo Pruneri; Andrea Viale; Francesco Bertolini
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

Review 8.  The therapeutic promise of the cancer stem cell concept.

Authors:  Natasha Y Frank; Tobias Schatton; Markus H Frank
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

9.  Rap2b, a novel p53 target, regulates p53-mediated pro-survival function.

Authors:  Xinyue Zhang; Yunlong He; Kyoung-Hwa Lee; Wendy Dubois; Ziqing Li; Xiaolin Wu; Alexander Kovalchuk; Weimin Zhang; Jing Huang
Journal:  Cell Cycle       Date:  2013-03-27       Impact factor: 4.534

Review 10.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.